Lysosomal Storage Disorders Flashcards
> 70 Lysosomal storage disorders
- Genetics
- incidence
GENETICS
- Most are AR
- 3 are X-linked
INCIDENCE
- as a group, 1:5,000
- individual, >1:50,000
How are LSDs different from other IEMs?
- slowly progressive (degenerative)
- not usually associated with acute metabolic derangements or with “metabolic crisis”
- common laboratory tests are often normal
Common LSD Clinical Manifestations
Failure to Thrive Abdominal distension with poor appetite Fatigue Bleeding diathesis Amennorrhea, menorrhagia Bone/joint pain sleep apnea Neural regression, loss of milestones, seizures, tremors, ayaxia
What are Mucopolysaccharidoses?
- 11 known lysosomal enzyme deficiences, 7 diff clinical types
- rare
- affect tissue storage of glycosaminoglycans
- progressive disorders with multisystemic involvement
Includes:
- Hurler
- Scheie
- Hunter
- Sanfilippo
- Morquio
Hurler syndrome (MPS I)
Deficiency of: enzyme alpha-L-iduronidase
Onset: > 6 mo
Rare
AR
3 forms: Hurler, Hurler-Scheie, Scheie
all patients have <1% of normal enzyme levels
Hurler MPS I-H symptoms
- *Valvular heart disease
- *Corneal clouding
- *Joint stiffness/contractures
- Obstructive airway disease
- Hearing loss
Death at age 3-10
SEVERE cognitive impairement
Progressive
Hurler-Scheie MPS I-H/S symptoms
- *Valvular heart disease
- *Corneal clouding
- *Joint stiffness/contractures
- Hearing loss
- Obstructive airway disease
Little to no intellectual defect
Death in late teens and 20s
Scheie MPS 1-S symptoms
- *Valvular heart disease
- *Corneal clouding
- *Joint stiffness
Normal intelligence
Less progressive physical problems
Death in later decades
Hurler syndrome clinical characteristics
Skeletal deformities
Short stature
Hepatosplenomegaly
Carpal tunnel syndrome and other nerve entrapments and compressions
Umbilical/inguinal hernia - often first clinical signs noted
Corneal clouding, may lead to blindness
- also common: retinal degradation
Coarse facial features
-
INVOLVES CNS*
remember: it’s progressive. more clinical signs appear as child ages
Hunter syndrome (MPS II)
- deficiency
- onset
- genetics
Deficiency of: iduronate-2-sulfatase
Onset: 1-3 yrs (severe form)
X-linked recessive
- carrier females do not show symptoms
- Rare
similar to MPS I, no corneal clouding
MPS II severe form
Onset: 1-3 yrs
Impaired intelligence
Life expectancy: 10-15 yrs
MPS II attenuated form
Gradual onset
Normal intelligence
Variable life expectancy
Hunter syndrome (MPSII) common features
PROGRESSIVE cognitive impairment Behavior problems - hyperactivity - obstinance - aggression - autistic-like Seizures Communicating hydrocephalus Hearing loss Decreased night and peripheral vision
UNIQUE: nodular skin lesions
Sanfilippo syndrome (MPS III)
- clinical manifestations
- genetics
4 disorders, all with the same clinical phenotype
CLINICAL MANIFESTATIONS:
- neurologic deterioration by 6-10 yrs old
- hyperactivity
- relatively mild somatic features
- death in teenage years
some mild forms, usually not detected
AR
Morquio syndrome (MPS IV
- genetics
- incidence
2 disorders with same clinical phenotype
- MPS IV-A
- MPS IV-B
both types have wide spectrum of clinical involvement
AR